Insufficient Antiretroviral Therapy in Pregnancy: Missed Opportunities for Prevention of Mother-To-Child Transmission of HIV in Europe
- 1 August 2011
- journal article
- research article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 16 (6) , 895-903
Abstract
Background: Although mother-to-child transmission (MTCT) rates are at an all-time low in Western Europe, potentially preventable transmissions continue to occur. Duration of antenatal combination antiretroviral therapy (ART) is strongly associated with MTCT risk. Methods: Data on pregnant HIV-infected women enrolled in the Western and Central European sites of the European Collaborative Study between January 2000 and July 2009 were analysed. The proportion of women receiving no antenatal ART or 1–13 days of treatment was investigated, and associated factors explored using logistic regression models. Results: Of 2,148 women, 142 (7%) received no antenatal ART, decreasing from 8% in 2000–2003 to 5% in 2004– 2009 (χ 2 =8.73; P<0.01). A further 41 (2%) received 1–13 days of ART. One-third (64/171) of women with ‘insufficient’ (0 or 1–13 days) antenatal ART had a late HIV diagnosis (in the third trimester or intrapartum), but half (85/171) were diagnosed before conception. Pre-term delivery <34 weeks was associated with receipt of no and 1–13 days antenatal ART (adjusted odds ratios [ORs] 2.9 [ P<0.01] and 4.5 [ P<0.01], respectively). History of injecting drug use was associated with an increased risk of no ART (adjusted OR 2.9; P<0.01) and severe symptomatic HIV disease with a decreased risk (adjusted OR 0.2; P<0.01). MTCT rates were 1.1% (15/1,318) among women with ≥14 days antenatal ART and 7.4% (10/136) among those with insufficient ART. Conclusions: Over the last 10 years, around one in 11 women in this study received insufficient antenatal ART, accounting for 40% of MTCTs. One-half of these women were diagnosed before conception, suggesting disengagement from care.Keywords
This publication has 38 references indexed in Scilit:
- Prevention of mother‐to‐child transmission of HIV in Denmark, 1994–2008HIV Medicine, 2010
- Mode of delivery in HIV‐infected pregnant women and prevention of mother‐to‐child transmission: changing practices in Western EuropeHIV Medicine, 2010
- Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conceptionSexually Transmitted Infections, 2008
- Antiretroviral treatment during pregnancyAIDS, 2008
- Hepatitis B or hepatitis C coinfection in HIV‐infected pregnant women in EuropeHIV Medicine, 2008
- Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?AIDS, 2008
- Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal CohortAIDS, 2008
- Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected womenHIV Medicine, 2008
- Time to Undetectable Viral Load after Highly Active Antiretroviral Therapy Initiation among HIV-Infected Pregnant WomenClinical Infectious Diseases, 2007
- Safety of Agents Used to Prevent Mother-to-Child Transmission of HIVDrug Safety, 2007